Topical nepafenac for treatment of exudative age-related macular degeneration

被引：11
作者：
Libondi, Teodosio [1 ]
Jonas, Jost B. [2 ]
机构：
[1] Univ Naples 2, Fac Med, Dept Ophthalmol, I-80100 Naples, Italy
[2] Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, D-6800 Mannheim, Germany
来源：
ACTA OPHTHALMOLOGICA | 2010年 / 88卷 / 02期
关键词：
INTRAVITREAL BEVACIZUMAB; TRIAMCINOLONE ACETONIDE; AVASTIN(R);
D O I：
10.1111/j.1755-3768.2008.01491.x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：e32 / e33
页数：2
相关论文
共 14 条
[1]   A prospective study on intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration of different durations [J].
Algvere, Peep V. ;
Steen, Bjoern ;
Seregard, Stefan ;
Kvanta, Anders .
ACTA OPHTHALMOLOGICA, 2008, 86 (05) :482-489
[2]   Celecoxib inhibits proliferation of retinal pigment epithelial and choroid-retinal endothelial cells by a cyclooxygenase-2-independent mechanism [J].
Amrite, Aniruddha C. ;
Kompella, Uday B. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (02) :749-758
[3]  
FRIMPONGBOATENG A, 2008, ACTA OPHTHALMOL
[4]   A Randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration - One year results [J].
Gillies, MC ;
Simpson, JM ;
Luo, W ;
Penfold, P ;
Hunyor, ABL ;
Chua, W ;
Mitchell, P ;
Billson, F .
ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (05) :667-673
[5]   Pegaptanib for neovascular age-related macular degeneration [J].
Gragoudas, ES ;
Adamis, AP ;
Cunningham, ET ;
Feinsod, M ;
Guyer, DR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2805-2816
[6]   Short-term complications of intravitreal injections of triamcinolone and bevacizumab [J].
Jonas, J. B. ;
Spandau, U. H. ;
Schlichtenbrede, F. .
EYE, 2008, 22 (04) :590-591
[7]   Intravitreal use of triamcinolone acetonide: an experimental clinical procedure [J].
Jonas, JB .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2005, 83 (05) :526-527
[8]   Visual acuity change after intravitreal bevacizumab for exudative age-related macular degeneration in relation to subfoveal membrane type [J].
Jonas, Jost B. ;
Libondi, Teodosio ;
Ihloff, Anna K. ;
Harder, Bjorn ;
Kreissig, Ingrid ;
Schlichtenbrede, Frank ;
Sauder, Gangolf ;
Spandau, Ulrich H. M. .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (05) :563-565
[9]   Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology [J].
Kern, Timothy S. ;
Miller, Casey M. ;
Du, Yunpeng ;
Zheng, Ling ;
Mohr, Susanne ;
Ball, Sherry L. ;
Kim, M. ;
Jamison, Jeffrey A. ;
Bingaman, David P. .
DIABETES, 2007, 56 (02) :373-379
[10]   Ranibizumab for neovascular age-related macular degeneration [J].
Rosenfeld, Philip J. ;
Brown, David M. ;
Heier, Jeffrey S. ;
Boyer, David S. ;
Kaiser, Peter K. ;
Chung, Carol Y. ;
Kim, Robert Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1419-1431
12